NutriKing DiaWay Tablets.
Natural health product licensed in Canada
- Licence holder
- Canvors Corporation Canada Ltd
- NPN or DIN-HM
- 80044399
- Status
- Active licence
- Licence date
- 26 August 2013
- Revision date
- 11 January 2018
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Thuja occidentalis Source : Sommité | 50 mg | Not calculated |
| L-Glutamine Source : L-Glutamine | 200 mg | Not calculated |
| Acide DL-alpha-lipoïque Source : Acide DL-alpha-lipoÏque | 20 mg | Not calculated |
| Glucomannane Source : Amorphophallus konjac - tubercule | 150 mg | Not calculated |
| Hydrastis canadensis Source : Racine | 20 mg | Not calculated |
Non-medicinal ingredients
Cire de Carnauba, Cellulose microcristalline, Dioxyde de silicium, Eau purifiée, Hydroxypropyl méthylcellulose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 3 days |
Uses authorised in Canada
Source of antioxidant for the maintenance of good health. Provides support for healthy glucose metabolism. Helps the body to metabolize fats. A factor in the maintenance of good health. Helps the body to metabolize proteins.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are undergoing Chemotherapy treatment. Consult a health care practitioner prior to use if you are taking blood thinners. Consult a health care provider prior to use if you are taking sedative drugs and/or barbiturates. Consult a health care practitioner if symptoms persist. Consult a health care practitioner prior to use if you have impaired liver function. Consult a health care practitioner if you are uncertain whether or not you are taking adequate folate. Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner if symptoms worsen. Consult a health care practitioner prior to use if you have a kidney disorder. Consult a health care practitioner prior to use if you have blood pressure problems. If you experience sweating, paleness, chills, headache, dizziness and/or confusion, discontinue use and consult a health care practitioner (as these may be symptoms of serious low blood sugar.
Source
Official Health Canada record, licence 80044399
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging